Drug Patent Expirations in October 2014

Drug Patent Expirations for October 2014

TradenameApplicantGeneric NamePatent NumberPatent Expiration
DENAVIRDenco Assetpenciclovir sodium5,866,581Oct 4, 2014
DENAVIRDenco Assetpenciclovir sodium6,124,304Oct 4, 2014
REMODULINUnited Theraptreprostinil5,153,222Oct 6, 2014
SYMBICORTAstrazenecabudesonide; formoterol fumarate dihydrate5,674,860Oct 7, 2014
SUPRANEBaxter Hlthcaredesflurane5,617,906*PEDOct 8, 2014
CHIROCAINEPurdue Pharma Lplevobupivacaine hydrochloride5,708,011Oct 13, 2014
COARTEMNovartisartemether; lumefantrine5,677,331Oct 14, 2014
CLIMARA PROBayer Hlthcareestradiol; levonorgestrel5,676,968Oct 14, 2014
VARITHENAProvensispolidocanolRE38919Oct 14, 2014
ATROVENT HFABoehringer Ingelheimipratropium bromide5,676,930Oct 14, 2014
VARITHENAProvensispolidocanolRE40640Oct 14, 2014
TYVASOUnited Theraptreprostinil5,153,222Oct 16, 2014
ORENITRAMUnited Theraptreprostinil diolamine5,153,222Oct 16, 2014
TOBINovartis Pharmstobramycin5,508,269Oct 19, 2014
BACTROBANGlaxosmithklinemupirocin calcium6,025,389Oct 20, 2014
AUBAGIOSanofi Aventis Usteriflunomide5,679,709Oct 21, 2014
CYCLOSETVerosciencebromocriptine mesylate5,679,685Oct 21, 2014
IMODIUM MULTI-SYMPTOM RELIEFMcneilloperamide hydrochloride; simethicone5,679,376Oct 21, 2014
PRAVIGARD PAC (COPACKAGED)Bristol Myers Squibbaspirin; pravastatin sodium5,622,985*PEDOct 22, 2014
PRAVACHOLBristol Myers Squibbpravastatin sodium5,622,985*PEDOct 22, 2014
VELCADEMillennium Pharmsbortezomib6,083,903Oct 28, 2014
VELCADEMillennium Pharmsbortezomib7,119,080Oct 28, 2014
VELCADEMillennium Pharmsbortezomib6,617,317Oct 28, 2014
IPLEXInsmedmecasermin rinfabate recombinant5,681,818Oct 28, 2014
VELCADEMillennium Pharmsbortezomib6,297,217Oct 28, 2014
RYTHMOL SRGlaxosmithkline Llcpropafenone hydrochloride5,681,588Oct 28, 2014
VELCADEMillennium Pharmsbortezomib6,747,150Oct 28, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride7,101,960*PEDOct 29, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride6,066,678*PEDOct 29, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride5,679,717*PEDOct 29, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride6,784,254*PEDOct 29, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride5,919,832*PEDOct 29, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride6,433,026*PEDOct 29, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride5,917,007*PEDOct 29, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: